Arcutis Biotherapeutics, Inc. ARQT Total Operating Expenses
Discontinued — last reported Q3 '23
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed November 3, 2023, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s total operating expenses?
- Arcutis Biotherapeutics, Inc. (ARQT) reported total operating expenses of $75.01M in Q3 2023.
- How has Arcutis Biotherapeutics, Inc.'s total operating expenses changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s total operating expenses decreased by 28.9% year-over-year, from $105.47M to $75.01M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.